1.
Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost.
Aihara Makoto, Otani Shin-ichiro, Kozaki Jun, Unoki Kazuhiko, Takeuchi Masamitsu, Minami Keiichiro et al.
J GlaucomaJan 201238 citationsClinical Trial
Switching from BAK-latanoprost to BAK-free travoprost improved ocular surface health (less SPK/hyperemia) while maintaining intraocular pressure control, suggesting a beneficial clinical alternative.